Welcome to our dedicated page for Roadzen SEC filings (Ticker: RDZN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Roadzen, Inc. filings document an operating insurance technology company incorporated in the British Virgin Islands with Nasdaq-listed ordinary shares and warrants. The company’s 8-K reports disclose material events involving AI insurance agents, underwriting and claims automation, VehicleCare claims-repair activity, presentations on its AI architecture, material agreements, and amendments to junior convertible note financing.
Roadzen’s proxy and shareholder-meeting filings cover board elections, auditor ratification, shareholder voting results, and director changes. Its securities disclosures also identify capital-structure terms, including ordinary shares and warrants exercisable for one ordinary share, alongside governance, financing, business-performance, and risk-related information tied to its AI, insurance, mobility, and repair-network operations.
Roadzen Inc. director Supurna VedBrat reported receiving a new stock option grant. On 09/15/2025, VedBrat was granted a stock option to buy 152,732 Roadzen ordinary shares at an exercise price of $2.00 per share. The option became exercisable on 09/15/2025 and will expire on 09/15/2032. Following this grant, VedBrat beneficially owned 152,732 derivative securities directly.
Roadzen Inc. director Ajay Shah reported a new stock option grant for 152,732 derivative securities. On 09/15/2025, he was awarded a stock option (right to buy) covering 152,732 ordinary shares at a conversion or exercise price of $2 per share. The option becomes exercisable on 09/15/2025 and expires on 09/15/2032. Following this transaction, Shah beneficially owned 152,732 derivative securities directly.
Roadzen Inc. director Diane Beth Glossman reported a new stock option grant. On September 15, 2025, she was awarded 190,915 stock options giving her the right to buy up to 190,915 ordinary shares. The options have an exercise price of $2 per share, were first exercisable on September 15, 2025, and expire on September 15, 2032. The Form 4 shows she now directly holds 190,915 derivative securities following this grant, and the options were granted at no cash cost to her.
Roadzen Inc. insider Rohan Malhotra, who serves as Chief Executive Officer, director and a 10% owner, reported buying 10,000 ordinary shares on 12/04/2025 at a weighted average price of $1.71 per share. These trades were executed in multiple transactions between $1.70 and $1.71.
After this purchase, Malhotra directly holds 829,837 ordinary shares. He is also deemed to beneficially own 17,577,213 ordinary shares held by Avacara Pte Ltd and 45,854 ordinary shares held by RM Securities LLC, while disclaiming beneficial ownership except for his pecuniary interest. In addition, he holds 5,616,485 ordinary shares underlying restricted stock units that are scheduled to fully vest on September 17, 2026, subject to his continuous service with Roadzen.
Roadzen Inc. (RDZN) Chief Executive Officer and Director Rohan Malhotra reported an open-market purchase of 12,000 ordinary shares on November 21, 2025 at a weighted average price of $1.43 per share. These trades occurred in multiple transactions at prices between $1.42 and $1.49. Following this purchase, he directly holds 819,837 ordinary shares and is reported as having beneficial ownership of additional shares held through Avacara Pte Ltd and RM Securities LLC, as well as 5,616,485 ordinary shares underlying restricted stock units that vest on September 17, 2026, subject to continued service.
Roadzen Inc. entered into a securities purchase agreement with an institutional investor to issue junior convertible notes in a registered public offering with up to an aggregate principal amount of $5,555,555. The notes will be sold for a gross purchase price of $5,000,000, mature 18 months from issuance, and bear interest at 14% per year, rising to 18% upon an event of default.
Principal of $925,000, less any earlier conversions, plus accrued interest is payable quarterly, starting three months after issuance. The notes are initially convertible into ordinary shares at $2.25 per share, subject to customary adjustments and a beneficial ownership cap of 4.99%, which a holder may adjust up to 9.99% with notice. Roadzen may redeem the notes early by paying principal, accrued interest and a make-whole amount, and the investor has additional redemption and conversion rights following events of default or certain future financings.
Roadzen Inc. is raising capital through an offering of $5,555,555 in aggregate principal amount of junior convertible notes, which can be converted into its Ordinary Shares. The notes are issued at an original issue discount of about 10%, providing gross proceeds of $5,000,000, and are expected to generate approximately $4.7 million in net proceeds after placement fees and expenses. The notes mature in eighteen months, carry a 14% annual interest rate that increases to 18% upon an event of default, and require quarterly payments of $925,000 or the outstanding principal, plus deferred amounts and accrued interest. The initial conversion price is $2.25 per share, subject to adjustment, with conversion limited by a 4.99% beneficial ownership cap that can be increased up to 9.99%. Roadzen plans to use the funds to repay payables, reduce higher-cost indebtedness, and for general corporate purposes, but discloses substantial doubt about its ability to continue as a going concern and highlights the high risk and potential for investors to lose their entire investment.
Roadzen Inc. (RDZN) filed an Amendment No. 1 to its Annual Report on Form 10-K to correct an administrative omission. The company is adding a consent from its independent registered public accounting firm and re-filing management certifications required under Sections 302 and 906 of the Sarbanes-Oxley Act. Other disclosures continue to describe conditions as of the original filing date and are not updated.
The filing also notes that the aggregate market value of Roadzen’s equity held by non‑affiliates was $50,896,581, based on a $1.19 share price on September 30, 2024, and that 74,290,986 ordinary shares were outstanding as of June 20, 2025.
Roadzen Inc. filed a current report describing that it released financial results for the three- and six-month periods ended September 30, 2025. The company announced these results in a press release dated November 14, 2025, which is attached as Exhibit 99.1 and incorporated by reference. The update is provided under the topic of results of operations and financial condition and is designated as information that is furnished, not filed, under securities law. Roadzen’s ordinary shares, with a par value of $0.0001 per share, trade on the Nasdaq Stock Market under the symbol RDZN, and its warrants, each exercisable for one ordinary share at an exercise price of $11.50 per share, trade under the symbol RDZNW.
Roadzen Inc. reports higher revenue but remains deeply loss-making and highly leveraged for the quarter ended September 30, 2025. Revenue grew to $13.7 million for the quarter and $24.5 million for the six months, up from $11.9 million and $20.8 million a year earlier, while quarterly net loss attributable to ordinary shareholders narrowed sharply to $2.1 million from $21.8 million.
Total assets were $41.5 million against total liabilities of $62.4 million, leaving a shareholders’ deficit of $28.0 million and a negative working capital position, with current liabilities of $61.3 million versus current assets of $34.1 million. Cash and cash equivalents, including restricted cash, were $5.2 million, and operating activities used $9.0 million of cash in the six-month period.
Management discloses substantial doubt about the company’s ability to continue as a going concern due to recurring losses, negative operating cash flows and a significant working capital deficit, but points to a mitigation plan involving debt restructuring, converting liabilities to equity and multiple equity raises under a Form S-3 shelf registration that have brought in several rounds of gross proceeds.